A Basu Selected Research

A Basu Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2000
11	Neoplasms (Cancer) 01/2016 - 01/2001
6	Hyperglycemia 01/2023 - 02/2000
5	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2000
5	Infections 12/2012 - 01/2000
4	Insulin Resistance 01/2023 - 02/2000
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 03/2001
3	Carcinoma (Carcinomatosis) 06/2019 - 01/2001
2	Chromosome Aberrations (Chromosome Abnormalities) 04/2015 - 01/2003
2	Diabetes Mellitus 07/2012 - 06/2001
2	Wounds and Injuries (Trauma) 02/2001 - 01/2001
1	Obesity 01/2023
1	Facial Paralysis (Facial Palsy) 08/2022
1	Pathologic Complete Response 01/2022
1	Residual Neoplasm 01/2022
1	Prediabetic State (Prediabetes) 01/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2019
1	Depressive Disorder (Melancholia) 01/2018
1	Breech Presentation 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016
1	Ascites 04/2015
1	Glucose Intolerance 06/2013
1	Melanoma (Melanoma, Malignant) 05/2013
1	Skin Neoplasms (Skin Cancer) 05/2013
1	Infectious Arthritis (Septic Arthritis) 12/2012
1	Arthritis (Polyarthritis) 12/2012
1	Necrosis 12/2012
1	Body Weight (Weight, Body) 12/2012
1	Staphylococcal Infections 12/2012
1	Pre-Eclampsia (Preeclampsia) 11/2012
1	Inflammation (Inflammations) 04/2012
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Sarcoma (Soft Tissue Sarcoma) 09/2011
1	Proteinuria 11/2010
1	Viremia 01/2010
1	Polyradiculoneuropathy (Polyradiculoneuritis) 07/2009
1	Brain Neoplasms (Brain Tumor) 02/2009
1	Lung Neoplasms (Lung Cancer) 02/2009
1	Solitary Kidney 02/2009
1	Glioblastoma (Glioblastoma Multiforme) 12/2007

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2000
10	Insulin (Novolin)FDA Link 01/2023 - 02/2000
4	Proteins (Proteins, Gene)FDA Link 06/2008 - 09/2000
4	Glucagon (Glukagon)FDA Link 07/2003 - 04/2000
3	Nonesterified Fatty Acids (NEFA)IBA 01/2023 - 06/2001
3	CreatinineIBA 04/2015 - 11/2010
3	Alemtuzumab (Campath)FDA Link 05/2013 - 03/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 01/2001
3	Protein Kinase C-epsilonIBA 06/2008 - 01/2001
3	Drinking WaterIBA 01/2003 - 05/2001
2	SteroidsIBA 08/2022 - 10/2002
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 04/2015
2	EnzymesIBA 04/2015 - 09/2011
2	Interferon-gamma (Interferon, gamma)IBA 12/2012 - 02/2000
2	ArsenicIBA 01/2003 - 05/2001
2	GlucokinaseIBA 06/2001 - 02/2000
2	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2001 - 04/2000
2	Protein Kinase CIBA 01/2001 - 01/2001
2	IsoenzymesIBA 01/2001 - 12/2000
1	MicronutrientsIBA 01/2020
1	NaphthalimidesIBA 04/2015
1	AntioxidantsIBA 04/2015
1	isoquinolineIBA 04/2015
1	Glutathione (Reduced Glutathione)IBA 04/2015
1	Urea (Carbamide)FDA LinkGeneric 04/2015
1	NitrogenIBA 04/2015
1	thymoglobulin FDA Link 05/2013
1	Gentamicins (Gentamicin)FDA LinkGeneric 12/2012
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2012
1	Advanced Glycation End ProductsIBA 11/2012
1	Receptor for Advanced Glycation End ProductsIBA 11/2012
1	RestonIBA 01/2012
1	Pyruvaldehyde (Methylglyoxal)IBA 09/2011
1	NADH DehydrogenaseIBA 09/2011
1	Lysine (L-Lysine)FDA Link 09/2011
1	Leflunomide (Arava)FDA LinkGeneric 01/2010
1	Cidofovir (Vistide)FDA Link 01/2010
1	Blood Glucose (Blood Sugar)IBA 07/2009
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2009
1	Glycerol (Glycerine)FDA LinkGeneric 11/2008
1	Pioglitazone (Actos)FDA Link 11/2008
1	Metformin (Glucophage)FDA LinkGeneric 11/2008
1	TNF-Related Apoptosis-Inducing LigandIBA 06/2008
1	Temozolomide (Temodar)FDA LinkGeneric 12/2007
1	LigandsIBA 04/2007
1	Therapeutic UsesIBA 04/2007

Therapy/Procedure

9	Therapeutics 01/2020 - 08/2001
5	Transplantation 05/2013 - 12/2004
3	Radiotherapy 01/2016 - 12/2007
2	Kidney Transplantation 05/2013 - 03/2004
1	Decompression 08/2022
1	Neoadjuvant Therapy 01/2022
1	Artificial Pancreas 01/2020
1	Mastectomy (Mammectomy) 06/2019
1	Adjuvant Chemotherapy 01/2016
1	Fetal Version (External Cephalic Version) 01/2016
1	Brachytherapy 01/2016
1	Drug Therapy (Chemotherapy) 04/2015
1	Organ Transplantation 07/2012
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2009